When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ABMD - Abiomed Non-GAAP EPS of $1.13 beats by $0.16 revenue of $261.18M beats by $9.71M
ABIOMED Inc.
Abiomed press release (NASDAQ:ABMD): Q3 Non-GAAP EPS of $1.13 beats by $0.16. Revenue of $261.18M (+12.7% Y/Y) beats by $9.71M. The company is increasing the lower end of its fiscal year 2022 revenue guidance to a range of $1,025 million to $1,030 million with growth of 21% - 22% versus prior year, vs. consensus of $1,020 million. The company expects its fiscal year 2022 non-GAAP operating margin* to be in the range of 24% - 25%.